In a recent study, researchers observe that FGF21 inhibits pulmonary fibrosis by activating the Nrf-2 pathway, hence inhibiting ECM accumulation, and finally holding back fibrogenesis in pulmonary tissue [10]. This evidence concerns the gene FGF21 and pulmonary fibrosis.